Tenaya Therapeutics Inc (NASDAQ: TNYA) kicked off on Monday, down -4.85%% from the previous trading day, before settling in for the closing price of $0.59. Over the past 52 weeks, TNYA has traded in a range of $0.36-$4.06.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company slipped by -15.48% over the past five years. While this was happening, its average annual earnings per share was recorded 39.68%. With a float of $134.18 million, this company’s outstanding shares have now reached $162.66 million.
Let’s look at the performance matrix of the company that is accounted for 97 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Tenaya Therapeutics Inc (TNYA) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Tenaya Therapeutics Inc is 17.51%, while institutional ownership is 28.52%. The most recent insider transaction that took place on May 16 ’25, was worth 615. In this transaction SVP, Finance of this company sold 1,390 shares at a rate of $0.44, taking the stock ownership to the 98,300 shares. Before that another transaction happened on May 16 ’25, when Company’s Chief Medical Officer sold 2,937 for $0.44, making the entire transaction worth $1,300. This insider now owns 171,856 shares in total.
Tenaya Therapeutics Inc (TNYA) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.18 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 39.68% per share during the next fiscal year.
Tenaya Therapeutics Inc (NASDAQ: TNYA) Trading Performance Indicators
Take a look at Tenaya Therapeutics Inc’s (TNYA) current performance indicators. Last quarter, stock had a quick ratio of 6.68.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.16, a number that is poised to hit -0.18 in the next quarter and is forecasted to reach -0.71 in one year’s time.
Technical Analysis of Tenaya Therapeutics Inc (TNYA)
Tenaya Therapeutics Inc (NASDAQ: TNYA) saw its 5-day average volume 2.16 million, a negative change from its year-to-date volume of 2.89 million. As of the previous 9 days, the stock’s Stochastic %D was 13.46%.
During the past 100 days, Tenaya Therapeutics Inc’s (TNYA) raw stochastic average was set at 22.57%, which indicates a significant decrease from 38.69% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 104.82% in the past 14 days, which was lower than the 155.01% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.4964, while its 200-day Moving Average is $1.3566. Nevertheless, the first resistance level for the watch stands at $0.5933 in the near term. At $0.6281, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.6561. If the price goes on to break the first support level at $0.5305, it is likely to go to the next support level at $0.5025. Assuming the price breaks the second support level, the third support level stands at $0.4677.
Tenaya Therapeutics Inc (NASDAQ: TNYA) Key Stats
The company with the Market Capitalisation of 90.86 million has total of 162,667K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -111,130 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -26,860 K.
